Jim Simons
ETON icon

Jim Simons’s Eton Pharmaceutcials ETON Stock Holding History

Jim Simons’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
52,300
-111,021
-68% -$3.26M ﹤0.01% 1983
2026
Q1 		$4.03M Sell
163,321
-42,379
-21% -$741K 0.01% 1496
2025
Q4 		$3.48M Sell
205,700
-118,921
-37% -$2.09M 0.01% 1547
2025
Q3 		$7.05M Sell
324,621
-81,279
-20% -$1.35M 0.01% 1291
2025
Q2 		$5.78M Buy
405,900
+131,900
+48% +$2.09M 0.01% 1432
2025
Q1 		$3.56M Buy
274,000
+80,900
+42% +$1.22M 0.01% 1641
2024
Q4 		$2.57M Buy
193,100
+109,700
+132% +$1.11M ﹤0.01% 1881
2024
Q3 		$500K Sell
83,400
-23,100
-22% -$97.6K ﹤0.01% 2791
2024
Q2 		$350K Buy
106,500
+41,469
+64% +$145K ﹤0.01% 2851
2024
Q1 		$244K Buy
65,031
+22,331
+52% +$97.5K ﹤0.01% 3159
2023
Q4 		$187K Sell
42,700
-500
-1% -$2K ﹤0.01% 3150
2023
Q3 		$180K Buy
43,200
+15,600
+57% +$60.2K ﹤0.01% 3123
2023
Q2 		$96K Buy
27,600
+14,200
+106% +$52.2K ﹤0.01% 3485
2023
Q1 		$52K Buy
+13,400
New +$48.9K ﹤0.01% 3655
2020
Q2 		– Sell
-36,283
Closed -$149K – 3534
2020
Q1 		$149K Buy
+36,283
New +$212K ﹤0.01% 3159

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jim Simons's ETON Position: Q2 2026 in Review

Jim Simons reduced its Eton Pharmaceutcials (ETON) stake by 68% in Q2 2026, selling an estimated $3.26M and leaving 52,300 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Jim Simons first reported a position in ETON in Q1 2020 and has held it in 15 quarters since. The position peaked at $7.05M in Q3 2025. 102 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Jim Simons held 52,300 shares of Eton Pharmaceutcials worth $1.89M as of Q2 2026.
  • Jim Simons sold 111,021 Eton Pharmaceutcials shares in Q2 2026, an estimated $3.26M.
  • Eton Pharmaceutcials made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #1983 holding.
  • Jim Simons first reported a position in Eton Pharmaceutcials in Q1 2020 and has held it in 15 quarters since.
  • Jim Simons's Eton Pharmaceutcials position peaked at $7.05M in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.